227 related articles for article (PubMed ID: 16180235)
1. Expression analysis of 6p22 genomic gain in retinoblastoma.
Orlic M; Spencer CE; Wang L; Gallie BL
Genes Chromosomes Cancer; 2006 Jan; 45(1):72-82. PubMed ID: 16180235
[TBL] [Abstract][Full Text] [Related]
2. Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma.
Grasemann C; Gratias S; Stephan H; Schüler A; Schramm A; Klein-Hitpass L; Rieder H; Schneider S; Kappes F; Eggert A; Lohmann DR
Oncogene; 2005 Sep; 24(42):6441-9. PubMed ID: 16007192
[TBL] [Abstract][Full Text] [Related]
3. Genomic differences between retinoma and retinoblastoma.
Sampieri K; Mencarelli MA; Epistolato MC; Toti P; Lazzi S; Bruttini M; De Francesco S; Longo I; Meloni I; Mari F; Acquaviva A; Hadjistilianou T; Renieri A; Ariani F
Acta Oncol; 2008; 47(8):1483-92. PubMed ID: 18785023
[TBL] [Abstract][Full Text] [Related]
4. KIF14 and E2F3 mRNA expression in human retinoblastoma and its phenotype association.
Madhavan J; Mitra M; Mallikarjuna K; Pranav O; Srinivasan R; Nagpal A; Venkatesan P; Kumaramanickavel G
Mol Vis; 2009; 15():235-40. PubMed ID: 19190782
[TBL] [Abstract][Full Text] [Related]
5. Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer.
Wu Q; Hoffmann MJ; Hartmann FH; Schulz WA
Mol Cancer; 2005 May; 4(1):16. PubMed ID: 15876350
[TBL] [Abstract][Full Text] [Related]
6. Profiling genomic copy number changes in retinoblastoma beyond loss of RB1.
Bowles E; Corson TW; Bayani J; Squire JA; Wong N; Lai PB; Gallie BL
Genes Chromosomes Cancer; 2007 Feb; 46(2):118-29. PubMed ID: 17099872
[TBL] [Abstract][Full Text] [Related]
7. Genomic amplification in retinoblastoma narrowed to 0.6 megabase on chromosome 6p containing a kinesin-like gene, RBKIN.
Chen D; Pajovic S; Duckett A; Brown VD; Squire JA; Gallie BL
Cancer Res; 2002 Feb; 62(4):967-71. PubMed ID: 11861365
[TBL] [Abstract][Full Text] [Related]
8. High expression of KIF14 in retinoblastoma: association with older age at diagnosis.
Madhavan J; Coral K; Mallikarjuna K; Corson TW; Amit N; Khetan V; George R; Biswas J; Gallie BL; Kumaramanickavel G
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4901-6. PubMed ID: 17962437
[TBL] [Abstract][Full Text] [Related]
9. E2F3 is the main target gene of the 6p22 amplicon with high specificity for human bladder cancer.
Oeggerli M; Schraml P; Ruiz C; Bloch M; Novotny H; Mirlacher M; Sauter G; Simon R
Oncogene; 2006 Oct; 25(49):6538-43. PubMed ID: 16953223
[TBL] [Abstract][Full Text] [Related]
10. Novel 6p rearrangements and recurrent translocation breakpoints in retinoblastoma cell lines identified by spectral karyotyping and mBAND analyses.
Paderova J; Orlic-Milacic M; Yoshimoto M; da Cunha Santos G; Gallie B; Squire JA
Cancer Genet Cytogenet; 2007 Dec; 179(2):102-11. PubMed ID: 18036396
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA (circ-0075804) promotes the proliferation of retinoblastoma via combining heterogeneous nuclear ribonucleoprotein K (HNRNPK) to improve the stability of E2F transcription factor 3 E2F3.
Zhao W; Wang S; Qin T; Wang W
J Cell Biochem; 2020 Jul; 121(7):3516-3525. PubMed ID: 32065448
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.
Hurst CD; Tomlinson DC; Williams SV; Platt FM; Knowles MA
Oncogene; 2008 Apr; 27(19):2716-27. PubMed ID: 18037967
[TBL] [Abstract][Full Text] [Related]
13. Defining a 0.5-mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reaction.
Evans AJ; Gallie BL; Jewett MA; Pond GR; Vandezande K; Underwood J; Fradet Y; Lim G; Marrano P; Zielenska M; Squire JA
Am J Pathol; 2004 Jan; 164(1):285-93. PubMed ID: 14695341
[TBL] [Abstract][Full Text] [Related]
14. KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers.
Corson TW; Huang A; Tsao MS; Gallie BL
Oncogene; 2005 Jul; 24(30):4741-53. PubMed ID: 15897902
[TBL] [Abstract][Full Text] [Related]
15. DEK oncoprotein regulates transcriptional modifiers and sustains tumor initiation activity in high-grade neuroendocrine carcinoma of the lung.
Shibata T; Kokubu A; Miyamoto M; Hosoda F; Gotoh M; Tsuta K; Asamura H; Matsuno Y; Kondo T; Imoto I; Inazawa J; Hirohashi S
Oncogene; 2010 Aug; 29(33):4671-81. PubMed ID: 20543864
[TBL] [Abstract][Full Text] [Related]
16. KIF14 as an oncogene in retinoblastoma: a target for novel therapeutics?
Basavarajappa HD; Corson TW
Future Med Chem; 2012 Nov; 4(17):2149-52. PubMed ID: 23190103
[No Abstract] [Full Text] [Related]
17. Loss of p75 neurotrophin receptor expression accompanies malignant progression to human and murine retinoblastoma.
Dimaras H; Coburn B; Pajovic S; Gallie BL
Mol Carcinog; 2006 May; 45(5):333-43. PubMed ID: 16555252
[TBL] [Abstract][Full Text] [Related]
18. Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma.
Dimaras H; Khetan V; Halliday W; Orlic M; Prigoda NL; Piovesan B; Marrano P; Corson TW; Eagle RC; Squire JA; Gallie BL
Hum Mol Genet; 2008 May; 17(10):1363-72. PubMed ID: 18211953
[TBL] [Abstract][Full Text] [Related]
19. The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties.
Pajovic S; Corson TW; Spencer C; Dimaras H; Orlic-Milacic M; Marchong MN; To KH; Thériault B; Auspitz M; Gallie BL
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7618-24. PubMed ID: 21862643
[TBL] [Abstract][Full Text] [Related]
20. Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells.
Olsson AY; Feber A; Edwards S; Te Poele R; Giddings I; Merson S; Cooper CS
Oncogene; 2007 Feb; 26(7):1028-37. PubMed ID: 16909110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
